Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin for Prevention of New-Onset Diabetes After Kidney Transplant
NCT01928199Phase 4Completed
- Sponsor
- Washington University School of Medicine
- Start
- Sep 2013
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sitagliptin in post-transplant diabetes mellitus (PTDM), sponsored by Washington University School of Medicine. Started Sep 2013; status: completed.
02
Drugs
sitagliptin
03
Conditions
post-transplant diabetes mellitus (PTDM)
Beyond the preview
Go deeper on NCT01928199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01928199.